- Home
- LFST vs CERT Comparison
LFST vs CERT Comparison
Compare LFST & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFST
- CERT
- Stock Information
- Founded
- LFST 2015
- CERT 2008
- Country
- LFST United States
- CERT United States
- Employees
- LFST N/A
- CERT N/A
- Industry
- LFST Medical/Nursing Services
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- LFST Health Care
- CERT Technology
- Exchange
- LFST Nasdaq
- CERT Nasdaq
- Market Cap
- LFST 1.9B
- CERT 1.9B
- IPO Year
- LFST 2021
- CERT 2020
- Fundamental
- Price
- LFST $4.14
- CERT $11.09
- Analyst Decision
- LFST Strong Buy
- CERT Buy
- Analyst Count
- LFST 5
- CERT 7
- Target Price
- LFST $8.50
- CERT $15.17
- AVG Volume (30 Days)
- LFST 2.6M
- CERT 1.7M
- Earning Date
- LFST 08-07-2025
- CERT 08-06-2025
- Dividend Yield
- LFST N/A
- CERT N/A
- EPS Growth
- LFST N/A
- CERT N/A
- EPS
- LFST N/A
- CERT N/A
- Revenue
- LFST $1,283,503,000.00
- CERT $394,498,000.00
- Revenue This Year
- LFST $15.27
- CERT $11.52
- Revenue Next Year
- LFST $13.94
- CERT $8.74
- P/E Ratio
- LFST N/A
- CERT N/A
- Revenue Growth
- LFST 16.31
- CERT 9.37
- 52 Week Low
- LFST $4.09
- CERT $8.64
- 52 Week High
- LFST $8.61
- CERT $16.18
- Technical
- Relative Strength Index (RSI)
- LFST 26.48
- CERT 51.91
- Support Level
- LFST $4.09
- CERT $10.08
- Resistance Level
- LFST $4.32
- CERT $11.32
- Average True Range (ATR)
- LFST 0.17
- CERT 0.47
- MACD
- LFST -0.01
- CERT 0.03
- Stochastic Oscillator
- LFST 6.37
- CERT 61.96
About LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The group y has a single operating and reportable segment of mental health services.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.